{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:17:53Z","timestamp":1776413873413,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.01.065","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T05:41:48Z","timestamp":1553665308000},"page":"A3-A5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S1","title":["A social justice perspective on access to human rabies vaccines"],"prefix":"10.1016","volume":"37","author":[{"given":"Diorbhail","family":"Wentworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-6884","authenticated-orcid":false,"given":"Katie","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel M.","family":"Thumbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athman","family":"Mwatondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gati","family":"Wambura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai Rui","family":"Chng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.01.065_b0005","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1126\/science.1256306","article-title":"Implementing Pasteur's vision for rabies elimination","volume":"345","author":"Lankester","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.01.065_b0010","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2019.01.065_b0015","first-page":"201","article-title":"Rabies vaccines and immunoglobulins: WHO position","volume":"16","author":"WHO","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.01.065_b0020","first-page":"30512","article-title":"The potential impact of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study","volume":"18","author":"WHO rabies modeling consortium","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.065_b0025","unstructured":"WHO, FAO, OIE, GARC. Zero by 30: The global strategic plan to end human deaths from dog-mediated rabies by 2030; 2018 <http:\/\/www.who.int\/rabies\/United_against_Rabies\/en\/>."},{"key":"10.1016\/j.vaccine.2019.01.065_b0030","unstructured":"Gavi \u2013 the Vaccine Alliance. Gavi Board starts framing Alliance's approach to 2021\u20132025 period. 2018 <https:\/\/www.gavi.org\/library\/news\/press-releases\/2018\/gavi-board-starts-framing-alliance-s-approach-to-21-25-period\/>."},{"key":"10.1016\/j.vaccine.2019.01.065_b0035","doi-asserted-by":"crossref","unstructured":"Sen A. Capability and wellbeing. In: Nussbaum M, Sen A, editors. The Quality of Life. Oxford: Clarendon Press; 1993. p. 30\u201353.","DOI":"10.1093\/0198287976.003.0003"},{"key":"10.1016\/j.vaccine.2019.01.065_b0040","series-title":"The Tanner Lectures on Human Values","first-page":"196","article-title":"Equality of what?","author":"Sen","year":"1980"},{"key":"10.1016\/j.vaccine.2019.01.065_b0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(04)17063-3","article-title":"Global health and moral values","volume":"364","author":"Alkire","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.01.065_b0050","series-title":"Health and social justice","author":"Ruger","year":"2009"},{"key":"10.1016\/j.vaccine.2019.01.065_b0055","article-title":"Universal health coverage, health systems strengthening, and the World Bank","volume":"358","author":"Tichenor","year":"2017","journal-title":"BMJ"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.065_b0060","doi-asserted-by":"crossref","first-page":"A45","DOI":"10.1016\/j.vaccine.2018.08.086","article-title":"The need to improve access to rabies post-exposure vaccines: lessons from Tanzania","volume":"37","author":"Changalucha","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.065_b0065","first-page":"38-","article-title":"Description and comparative cost efficiency of post-exposure prophylaxis and canine mass vaccination against rabies in N'Djamena, Chad","volume":"4","author":"Mindekem","year":"2017","journal-title":"Front VetSci"},{"key":"10.1016\/j.vaccine.2019.01.065_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/wbro\/lks009","article-title":"The impact of health insurance schemes for the informal sector in low- and middle-income countries: a systematic review","author":"Acharya","year":"2013","journal-title":"World Bank Res Observ"},{"key":"10.1016\/j.vaccine.2019.01.065_b0075","unstructured":"Rajeev M, Edosoa G, Hanitriniaina C, Adriamandimby SF, Guis H, Ramiandrasoa R et al. Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar. Vaccine 2018;S0264-410X(18)31520-2."},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.065_b0080","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1016\/j.vaccine.2019.05.035","article-title":"Rabies vaccine and immunoglobulin supply and logistics: challenges and opportunities for rabies elimination in Kenya","volume":"37","author":"Wambura","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.065_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000511","article-title":"Rabies situation in Cambodia","volume":"3","author":"Ly","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.01.065_b0090","article-title":"Improving systematic rabies surveillance in Cameroon: a pilot initiative and results for 2014\u20132016","volume":"12","author":"Sofeu","year":"2018","journal-title":"PLoS NeglTrop Dis"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.065_b0095","doi-asserted-by":"crossref","first-page":"A14","DOI":"10.1016\/j.vaccine.2018.10.011","article-title":"Descriptive assessment of rabies post-exposure prophylaxis procurement, distribution, monitoring, and reporting in four Asian countries: Bangladesh, Bhutan, Cambodia, and Sri Lanka, 2017\u20132018","volume":"37","author":"Li","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.065_b0100","doi-asserted-by":"crossref","unstructured":"Waithaka D, Tsofa B, Barasa E. Evaluating healthcare priority setting at the meso level: a thematic review of empirical literature. Wellcome Open Research 2018;3:2.","DOI":"10.12688\/wellcomeopenres.13393.2"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.065_b0105","doi-asserted-by":"crossref","first-page":"A166","DOI":"10.1016\/j.vaccine.2018.11.010","article-title":"Modelling to inform prophylaxis regimens to prevent human rabies","volume":"37","author":"Hampson","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.065_b0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(83)90288-X","article-title":"An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis","volume":"2","author":"Warrell","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.01.065_b0115","doi-asserted-by":"crossref","unstructured":"Robeyns I. The capability approach: a theoretical survey. J Human Dev 2005;6:93\u2013117.","DOI":"10.1080\/146498805200034266"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.065_b0120","doi-asserted-by":"crossref","first-page":"A118","DOI":"10.1016\/j.vaccine.2018.10.054","article-title":"Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003\u20132014","volume":"37","author":"Tarantola","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.065_b0125","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.aaq1081","article-title":"Expanded health systems for sustainable development","volume":"23","author":"Dye","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.01.065_b0130","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0168","article-title":"One health contributions towards more effective and equitable approaches to health in low- and middle-income countries","author":"Cleaveland","year":"2017","journal-title":"Philos Trans Roy Soc B-Biol Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:33Z","timestamp":1759401273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":26,"alternative-id":["S0264410X19301501"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A social justice perspective on access to human rabies vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}